Back
Bone Biologics Corp. 10K Form
Sell
24
BBLG
Bone Biologics Corp.
Last Price:
$1.23
Seasonality Move:
-14%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BBLG News And Ratings
See the #1 stock for the next 7 days that we like better than BBLG
BBLG Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-714.8K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.00 |
| Price / Book: | 0.44 |
Profitability
| EPS (TTM): | -3.99750 |
|---|---|
| Net Income (TTM): | $-3.1M |
| Gross Margin: | $0 |
| Return on Equity: | -63.75% |
| Return on Assets: | -59.39% |
Bone Biologics Corp. Earnings Forecast
Key Bone Biologics Corp. Financial Ratios
-
Per Share Earnings over the last 16 years have been positive in 9 years.
Bone Biologics Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | BBLG |
| Website: | bonebiologics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 13.85 |
| Quick Ratio: | 12.74 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BBLG Technical Analysis vs Fundamental Analysis
Sell
24
Bone Biologics Corp. (BBLG)
is a Sell
Is Bone Biologics Corp. a Buy or a Sell?
-
Bone Biologics Corp. stock is rated a SellThe current Bone Biologics Corp. [BBLG] share price is $1.24. The Score for BBLG is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.